Search companies or stocks...
For Clinuvel Pharmaceuticals Limited (CUV), the latest fiscal-year data shows a dividend yield of 0.48% and a payout ratio of 6.92%. Together, these metrics help you judge how much earnings are returned as dividends and whether the payout looks supported. Review the FY summary and payout history tables below to see the trend over time.
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividends per share (FY) | $0.05 | $0.05 | $0.05 | $0.04 | $0.03 | $0.03 | $0.03 | $0.02 |
| Dividend yield (FY) % | 0.48% | 0.32% | 0.22% | 0.17% | 0.08% | 0.10% | 0.06% | 0.00% |
| Payout ratio (FY) % | 6.92% | 6.93% | 6.46% | 5.92% | 5.00% | 7.35% | 5.28% | 0.00% |
| Pay Date | Ex-Date | Record Date | Amount |
|---|---|---|---|
| 2025-09-19 | September 04, 25 | 2025-09-05 | $0.05 |
| 2024-09-20 | September 05, 24 | 2024-09-06 | $0.05 |
| 2023-09-20 | September 05, 23 | 2023-09-06 | $0.05 |
| 2022-09-21 | September 06, 22 | 2022-09-07 | $0.04 |
| 2021-09-17 | September 02, 21 | 2021-09-03 | $0.03 |
| 2020-09-18 | September 03, 20 | 2020-09-04 | $0.03 |
| 2019-09-19 | September 04, 19 | 2019-09-05 | $0.03 |
| 2018-10-08 | September 21, 18 | 2018-09-24 | $0.02 |
The dividend yield shows how much Clinuvel Pharmaceuticals Limited returns to shareholders relative to its stock price, while the payout ratio indicates how much of its earnings are distributed. Monitoring these metrics helps investors evaluate whether the dividend is sustainable and supported by earnings or cash flow.
By reviewing the historical dividend payouts for Clinuvel Pharmaceuticals Limited, investors can identify trends in growth or cuts. Consistent or rising dividends over time often signal financial stability, while decreasing dividends may indicate potential risks or shifts in business strategy. Use the FY summary and payout history tables to track changes across multiple years.
Comparing Clinuvel Pharmaceuticals Limited's dividend yield with similar companies in the same sector helps gauge relative attractiveness. A higher yield can be appealing for income-focused investors, but it's important to assess sustainability alongside profitability and balance-sheet strength. Use the related peers section to benchmark dividend yield and payout characteristics.
Analyzing Clinuvel Pharmaceuticals Limited's liquidity, cash flow, and debt levels provides insight into whether it can sustain dividend payments during economic volatility. Stocks with strong financial health are more likely to maintain consistent dividends even when markets fluctuate. Pair dividend metrics with the FY payout ratio and the multi-year history tables for context.
Investors often include Clinuvel Pharmaceuticals Limited dividends in a long-term portfolio to generate passive income. Assessing dividend yield, payout ratio, growth history, and financial stability helps determine whether the company fits an income-focused or total-return investment strategy. Review the dividend summary and payout history tables to validate consistency over time.
